2026 Q1 Portfolio Activity
In 2026 Q1, Boxer Capital Management, LLC maintained a portfolio of 58 distinct positions. The most significant new addition was VAXCYTE INC, now representing 2.48% of the total fund value. They heavily accumulated shares in VIR BIOTECHNOLOGY INC, increasing the position by 198.6%. Conversely, Boxer Capital Management, LLC completely exited their position in CIDARA THERAPEUTICS INC.
Position History
hover any row below to update
Loading…
Total Positions
58
Quarter
2026 Q1
Top Holding
TNGX (29.9%)
Top 10 Concentration
63.3%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 58
Boxer Capital Management, LLC Full Holdings List — 2026 Q1
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
TNGX
TANGO THERAPEUT...
|
Healthcare | 29.87% | 21.09% |
#1
Prev: #1
|
7.0 | no change | no change |
P
S
|
10,876,219 | $227,530,501 |
$8.86
+144.1%
|
2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
KOD
KODIAK SCIENCES...
|
Healthcare | 6.81% | 6.95% |
#2
1
Prev: #3
|
6.2 | 225,000 | 19.8% |
P
S
|
1,361,000 | $51,881,320 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 6.38% | 6.97% |
#3
1
Prev: #2
|
6.1 | 100,000 | 25.0% |
P
S
|
500,000 | $48,625,000 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
KYMR
KYMERA THERAPEU...
|
Healthcare | 3.60% | 5.60% |
#4
Prev: #4
|
2.9 | no change | no change |
P
S
|
329,100 | $27,410,739 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CELC
CELCUITY INC
|
Healthcare | 3.37% | 4.91% |
#5
Prev: #5
|
2.8 | no change | no change |
P
S
|
225,000 | $25,681,500 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SRZN
SURROZEN INC
|
Healthcare | 2.93% | 2.06% |
#6
9
Prev: #15
|
4.2 | 350,168 | 84.1% |
P
S
|
766,318 | $22,322,843 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ABVX
ABIVAX SA
|
Healthcare | 2.92% | 3.69% |
#7
1
Prev: #6
|
4.2 | 75,000 | 60.0% |
P
S
|
200,000 | $22,270,000 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
TERN
TERNS PHARMACEU...
|
Healthcare | 2.60% | 3.32% |
#8
Prev: #8
|
2.0 | no change | no change |
P
S
|
375,000 | $19,770,000 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PCVX
VAXCYTE INC
|
Healthcare | 2.48% | — |
#9
Prev: #—
|
4.5 | 325,000 | — |
NEW
|
325,000 | $18,885,750 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CAPR
CAPRICOR THERAP...
|
Healthcare | 2.35% | 2.05% |
#10
6
Prev: #16
|
3.9 | 265,000 | 81.5% |
P
S
|
590,000 | $17,936,000 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PTGX
PROTAGONIST THE...
|
Healthcare | 2.35% | 3.25% |
#11
2
Prev: #9
|
1.9 | no change | no change |
P
S
|
170,000 | $17,918,000 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
VIR
VIR BIOTECHNOLO...
|
Healthcare | 2.20% | 0.82% |
#12
19
Prev: #31
|
3.9 | 1,241,000 | 198.6% |
P
S
|
1,866,000 | $16,719,360 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CRVS
CORVUS PHARMACE...
|
Healthcare | 2.11% | — |
#13
Prev: #—
|
4.3 | 1,100,000 | — |
NEW
|
1,100,000 | $16,093,000 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 1.97% | 3.00% |
#14
4
Prev: #10
|
1.8 | no change | no change |
P
S
|
46,457 | $14,967,981 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PTCT
PTC THERAPEUTIC...
|
Healthcare | 1.79% | 3.33% |
#15
8
Prev: #7
|
1.7 | no change | no change |
P
S
|
200,000 | $13,626,000 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PGEN
PRECIGEN INC
|
Healthcare | 1.78% | 1.26% |
#16
7
Prev: #23
|
3.7 | 2,125,000 | 154.5% |
P
S
|
3,500,000 | $13,545,000 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
DFTX
DEFINIUM THERAP...
|
Healthcare | 1.49% | — |
#17
Prev: #—
|
4.1 | 598,500 | — |
NEW
|
598,500 | $11,311,650 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AMLX
AMYLYX PHARMACE...
|
Healthcare | 1.46% | 2.12% |
#18
4
Prev: #14
|
1.6 | no change | no change |
P
S
|
800,000 | $11,120,000 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
QURE
UNIQURE NV
|
Healthcare | 1.42% | 1.52% |
#19
1
Prev: #20
|
3.6 | 372,000 | 128.3% |
P
S
|
662,000 | $10,823,700 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
IRD
OPUS GENETICS I...
|
Healthcare | 1.34% | — |
#20
Prev: #—
|
4.0 | 2,250,000 | — |
NEW
|
2,250,000 | $10,237,500 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CORT
CORCEPT THERAPE...
|
Healthcare | 1.32% | — |
#21
Prev: #—
|
4.0 | 250,000 | — |
NEW
|
250,000 | $10,077,500 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
URGN
UROGEN PHARMA L...
|
Healthcare | 1.18% | 2.56% |
#22
11
Prev: #11
|
1.5 | no change | no change |
P
S
|
500,000 | $8,990,000 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
REPL
REPLIMUNE GROUP...
|
Healthcare | 1.18% | 1.60% |
#23
4
Prev: #19
|
3.5 | 425,000 | 56.7% |
P
S
|
1,175,000 | $8,988,750 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 1.14% | 1.75% |
#24
6
Prev: #18
|
1.5 | no change | no change |
P
S
|
225,000 | $8,660,250 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PALI
PALISADE BIO IN...
|
Healthcare | 1.10% | 2.47% |
#25
12
Prev: #13
|
1.4 | no change | no change |
P
S
|
4,799,875 | $8,399,781 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
N/A
CRESCENT BIOPHA...
|
|
Unknown | 1.09% | — |
#26
Prev: #—
|
3.9 | 453,686 | — |
NEW
|
453,686 | $8,334,212 | — | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
SLNO
SOLENO THERAPEU...
|
Healthcare | 0.88% | — |
#27
Prev: #—
|
3.9 | 200,000 | — |
NEW
|
200,000 | $6,696,000 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ALLO
ALLOGENE THERAP...
|
Healthcare | 0.87% | — |
#28
Prev: #—
|
3.8 | 2,725,000 | — |
NEW
|
2,725,000 | $6,649,000 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CYTK
CYTOKINETICS IN...
|
Healthcare | 0.87% | 1.39% |
#29
8
Prev: #21
|
1.3 | no change | no change |
P
S
|
100,000 | $6,591,000 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CTNM
CONTINEUM THERA...
|
Healthcare | 0.85% | 1.24% |
#30
6
Prev: #24
|
1.3 | no change | no change |
P
S
|
494,000 | $6,451,640 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
APGE
APOGEE THERAPEU...
|
Healthcare | 0.77% | 1.16% |
#31
5
Prev: #26
|
1.3 | no change | no change |
P
S
|
70,000 | $5,891,900 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RLMD
RELMADA THERAPE...
|
Healthcare | 0.77% | — |
#32
Prev: #—
|
3.8 | 842,106 | — |
NEW
|
842,106 | $5,861,058 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ZURA
ZURA BIO LTD
|
Healthcare | 0.70% | 0.06% |
#33
10
Prev: #43
|
3.3 | 850,000 | 1700.0% |
P
S
|
900,000 | $5,355,000 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MLTX
MOONLAKE IMMUNO...
|
Healthcare | 0.67% | 0.79% |
#34
1
Prev: #33
|
1.3 | no change | no change |
P
S
|
275,000 | $5,126,000 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AVTX
AVALO THERAPEUT...
|
Healthcare | 0.59% | 1.09% |
#35
7
Prev: #28
|
2.2 | 25,000 | 9.1% |
P
S
|
300,000 | $4,479,000 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
INO
INOVIO PHARMACE...
|
Healthcare | 0.54% | 0.92% |
#36
7
Prev: #29
|
0.7 | -50,000 | -2.1% |
P
S
|
2,370,122 | $4,124,012 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
GPCR
STRUCTURE THERA...
|
Healthcare | 0.47% | 1.14% |
#37
10
Prev: #27
|
1.2 | no change | no change |
P
S
|
75,000 | $3,615,000 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SRPT
SAREPTA THERAPE...
|
Healthcare | 0.43% | 0.71% |
#38
4
Prev: #34
|
1.2 | no change | no change |
P
S
|
150,000 | $3,264,000 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CYBN
CYBIN INC
|
Unknown | 0.40% | 1.28% |
#39
17
Prev: #22
|
0.7 | -75,000 | -10.5% |
P
S
|
640,000 | $3,072,000 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
OCUL
OCULAR THERAPEU...
|
Healthcare | 0.39% | — |
#40
Prev: #—
|
3.7 | 350,000 | — |
NEW
|
350,000 | $2,964,500 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ANTX
AN2 THERAPEUTIC...
|
Healthcare | 0.34% | — |
#41
Prev: #—
|
3.6 | 749,035 | — |
NEW
|
749,035 | $2,561,700 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CLNN
CLENE INC
|
Consumer Defensive | 0.31% | 0.26% |
#42
1
Prev: #41
|
3.1 | 277,778 | 139.1% |
P
S
|
477,515 | $2,354,149 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ORIC
ORIC PHARMACEUT...
|
Healthcare | 0.29% | — |
#43
Prev: #—
|
3.6 | 176,500 | — |
NEW
|
176,500 | $2,236,255 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SLDB
SOLID BIOSCIENC...
|
Healthcare | 0.28% | 0.37% |
#44
6
Prev: #38
|
1.1 | no change | no change |
P
S
|
300,000 | $2,160,000 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
IVVD
INVIVYD INC
|
Healthcare | 0.26% | 0.81% |
#45
13
Prev: #32
|
1.1 | no change | no change |
P
S
|
1,500,000 | $1,950,000 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
LBRX
LB PHARMACEUTIC...
|
Healthcare | 0.23% | 0.34% |
#46
7
Prev: #39
|
1.1 | no change | no change |
P
S
|
70,000 | $1,726,200 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
KPTI
KARYOPHARM THER...
|
Healthcare | 0.22% | 0.41% |
#47
10
Prev: #37
|
2.1 | 50,000 | 19.8% |
P
S
|
302,536 | $1,685,126 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
NRIX
NURIX THERAPEUT...
|
Healthcare | 0.20% | 0.42% |
#48
12
Prev: #36
|
1.1 | no change | no change |
P
S
|
100,000 | $1,550,000 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
UPB
UPSTREAM BIO IN...
|
Healthcare | 0.18% | 0.89% |
#49
19
Prev: #30
|
1.1 | no change | no change |
P
S
|
150,000 | $1,350,000 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MIST
MILESTONE PHARM...
|
Healthcare | 0.10% | 0.29% |
#50
10
Prev: #40
|
1.0 | no change | no change |
P
S
|
666,666 | $793,333 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 |
Showing 1-50 of 58 holdings